Are you familiar with the groundbreaking advancements in post-surgical adhesion prevention? FzioMed, Inc., a global leader in the field, recently made waves at the ESGE Congress by highlighting their cutting-edge Oxiplex/IU and Oxiplex/AP gels.
Revolutionizing Adhesion Prevention
Patented Technology for Enhanced Recovery
FzioMed's gels, built on patented technology, have been designed to significantly reduce adhesion formation post intrauterine and abdominal/pelvic surgeries. By utilizing these innovative adhesion barriers, patients can steer clear of potential complications such as chronic pain, infertility, and obstructions.
Years of Clinical Success
What sets FzioMed's products apart is their user-friendly nature - they are ready to use, clear, and non-migratory after application. With a track record of over 20 years of clinical use and nearly 1 million procedures performed globally, FzioMed is a trusted name in the industry.
A Focus on Innovation
FzioMed is dedicated to advancing biomaterial development across various medical specialties, including spine, orthopedic, abdominal/pelvic, and gynecological procedures. By offering state-of-the-art solutions for surgical adhesion prevention, FzioMed is paving the way for safer and more effective post-operative care. If you're intrigued by the future of adhesion prevention, keep an eye on FzioMed, Inc. for the latest updates and advancements.